Market revenue in 2023 | USD 37.4 million |
Market revenue in 2030 | USD 51.9 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Molecular diagnostics |
Fastest growing segment | Immunoassays |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy |
Key market players worldwide | Quest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.
Molecular diagnostics was the largest segment with a revenue share of 25.4% in 2023. Horizon Databook has segmented the Denmark laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.
In Denmark, some of the companies involved in the LDTs market include Novo Nordisk, Hologic, and Roche Diagnostics. These companies are constantly working to develop LDTs that can help healthcare providers diagnose and treat a wide range of diseases & conditions.
Furthermore, the increasing popularity of personalized medicine in Denmark led to an increase in the development & use of LDTs, which can provide more personalized and accurate diagnostic information. In December 2021, Hologic announced the launch of Panther Trax, which aims for high-volume molecular testing.
The Panther system offers wide range of assay options that include tests for Sexually Transmitted Infections (STIs), women’s health, and respiratory health, along with open-access functionality for LDTs.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into Denmark laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account